Method for determining lung adenocarcinomas by assaying for one

Details Method for determining lung adenocarcinomas by assaying for one Method for determining lung adenocarcinomas by assaying for one

1994-03-10

1998-06-09

Zitomer, Stephanie W.

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

435 912, C12Q 168, C12P 1934

Patent

active

057631654

ABSTRACT:
A method for determining lung adenocarcinomas is described. The method involves assaying for expression of a gene coding for at least one of tumor rejection antigen precursors MAGE-1, 2 and 3, or their expression product.

REFERENCES:
patent: 5342774 (1994-08-01), Boon et al.
Smet et al, Immunogenetic 39:121-129 (1994).
Van der Bruggen, et al., "A Gene Encoding An Antigen Recognized By Cytolytic T Lymphocytes On A Human Melanoma", Science 254: 1643-1647 (Feb. 13, 1991).
Brasseur, et al., "Human Gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some tumors", Int. J. Cancer 52: 839-841 (1991).

Affiliated with

Also associated with

Rating

Method for determining lung adenocarcinomas by assaying for one does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for determining lung adenocarcinomas by assaying for one , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for determining lung adenocarcinomas by assaying for one will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2197648